Challenges associated with Ph+ ALL: identifying high-risk patients & novel therapies being explored скачать в хорошем качестве

Challenges associated with Ph+ ALL: identifying high-risk patients & novel therapies being explored

In this video, Josep-Maria Ribera, MD, PhD, Germans Trias i Pujol University Hospital, Barcelona, Spain, discusses a debate at ESH AL 2026 that focused on the treatment of patients with Ph-positive acute lymphoblastic leukemia (Ph+ ALL). He highlights the challenges of treating a subset of high-risk patients who still relapse despite modern chemotherapy, and notes that new therapies, including next-generation TKIs, combination approaches, and the early use of CAR T-cells, may offer promising solutions. This interview took place at the 5th How to Diagnose and Treat: Acute Leukemias meeting of the European School of Hematology (ESH AL) in Mandelieu-La Napoule, France. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.